RGS1 and AL amyloidosis: For instance, RGS1 is highly expressed in multiple myeloma and is a promising target for the treatment of multiple myeloma as a prognostic marker by desensitizing or stimulating receptor activity, thereby altering the GPCR signaling pathway and its downstream activity (Roh et al., 2017).